With ADHD diagnoses and prescriptions on the rise, there’s a growing need for accessible, preliminary screening tools that guide users toward professional help. Many people experience attention-related challenges but hesitate to seek clinical evaluation due to cost, stigma, or uncertainty. Existing solutions either require in-person visits or offer generic symptom tracking without actionable next steps—creating a gap this idea could fill.
One approach might involve creating a digital tool that offers structured ADHD screening without claiming to diagnose. It could use clinically validated questionnaires (like the ASRS-v1.1) to evaluate symptoms, then generate a simple report highlighting potential concerns while stressing the need for professional input. To add value, it might:
The tool could differentiate itself by focusing on triage—bridging the gap between suspicion of symptoms and clinical care—rather than replacing professional assessment.
Such a tool could help three key groups:
Potential revenue streams might include partnerships with telehealth platforms (for referral fees) or premium features like detailed reports. However, clear disclaimers would be critical to avoid regulatory issues and prevent misuse.
An MVP could start as a web-based questionnaire using free, validated screening tools, paired with generic recommendations. Early iterations might add symptom tracking or provider directories based on user feedback. Piloting with clinicians could help refine the tool’s utility, while partnerships with telehealth services might streamline transitions from screening to consultation.
By focusing on guiding users rather than diagnosing them, this approach could address hesitations around seeking help while supporting overburdened healthcare systems.
Hours To Execute (basic)
Hours to Execute (full)
Estd No of Collaborators
Financial Potential
Impact Breadth
Impact Depth
Impact Positivity
Impact Duration
Uniqueness
Implementability
Plausibility
Replicability
Market Timing
Project Type
Digital Product